Press Releases

Scientists find new use for popular heartburn drugNov 7, 2019
A team of scientists from Baylor College of Medicine found that proton pump inhibitors could be used as a potential therapy for radiation-induced complications.
Factors linked to poor treatment outcomes in ALLOct 24, 2019
Researchers reported that profiling the bone marrow “metabolome" at the time of pediatric acute lymphoblastic leukemia diagnosis enabled them to identify patients who were most likely to respond poorly to treatment.
Researchers to study liquid biopsy test for cancerOct 15, 2019
Researchers at Baylor Genetics and Miraca Research Institute are working to develop a minimally invasive tool that could diagnose cancer with a blood test.
DNA fracturing rewires gene control in cancerOct 15, 2019
A new study has brought attention to genomic structural variation as a previously unappreciated mechanism involved in altering DNA methylation, a form of gene control, in human cancers.
Susan G. Komen® honors Dr. Matthew Ellis with Brinker AwardOct 3, 2019
Dr. Matthew Ellis has been awarded the Susan G. Komen® Brinker Award for Scientific Distinction in Clinical Research.
Passport for Care plans for childhood cancer survivor's futureSep 24, 2019
Passport for Care is a free online resource developed by Baylor College of Medicine and Texas Children’s Cancer Center that provides a survivorship care plan for both the survivor and their doctor.
Grant funds action against youth e-cigarette usageSep 9, 2019
With concerns rising over the health effects of vaping, doctors and researchers at Baylor College of Medicine are taking preventative action. 
Study of prostate cancer in African-American men recruitingAug 27, 2019
Researchers are trying to find out why one in six African-American men will be diagnosed with prostate cancer, and why they are twice as likely as white men to die from it.
Cell roles in immunotherapy-resistant breast cancer profiledAug 26, 2019
To better understand the specific roles different immune cell types play, a multi-institutional team profiled the immune cell composition of multiple murine models and clinical datasets of triple negative breast cancers.
Researchers share Harvey health impact findings at symposiumAug 5, 2019
Researchers have been studying Hurricane Harvey's effect on public health and the emergency response by healthcare providers during a major disaster. On Thursday, Aug. 22, they will share what they have learned at a symposium.
p53 mutations in cancer patients shed light on gene’s functionJul 30, 2019
Researchers at Baylor College of Medicine have conducted a  study of TP53 mutations to better understand the processes leading to the inactivation of this important gene. 
Clinical trial uses immunotherapy to treat mesotheliomaJul 23, 2019
The Mesothelioma Treatment Center at the Baylor College of Medicine Lung Institute is looking for malignant pleural mesothelioma patients to try a new treatment that combines immunotherapy with a new drug that accelerates cell death.
Anal cancer precursors for women with HIV greater than previously reportedJul 12, 2019
The prevalence of anal high-grade squamous intraepithelial lesions, which precede anal cancer, is much higher in women living with HIV than previously reported.
Expert dispels common colorectal cancer surgery mythsJun 27, 2019
Dr. Atif Iqbal dispels some common myths and explains how Baylor College of Medicine's multidisciplinary approach to treating these cancers improves patient outcomes.
Study reveals elevated cancer risk in children with birth defectsJun 20, 2019
A collaborative team of scientists led by Baylor College of Medicine has assembled the largest study to date to evaluate cancer risk in children with birth defects.
Viswanathan receives NIH grant to study treatment for cancer-related pain Jun 20, 2019
Dr. Ashwin Viswanathan has been awarded a Research Project Grant (R01) of more than $2 million by the National Institutes of Health.
Cancer immunotherapy clinical study approved for phase 1Jun 7, 2019
A cancer immunotherapy research group at Baylor College of Medicine has secured Investigational New Drug regulatory clearance through the FDA to perform phase I clinical studies in newly-diagnosed adult patients with glioblastoma.
Study searches for families with gliomaMay 15, 2019
Gliogene, a study that aims to identify hereditary links of glioma, a rare and deadly form of brain cancer, has begun recruiting families affected by the disease in order to identify genes that contribute to its onset and inform susceptibility.
Ethical concerns of oncology trial-finding appsMay 13, 2019
In a new study, ethics scholar Dr. Stephanie Morain explores a trend of oncology trial recruitment via mobile apps, and what these app companies and consumers need to consider in terms of privacy and data protection
First-in-human trial shows promise in treating neuroblastomaApr 30, 2019
In a promising development, researchers released initial findings from the first two patients treated in a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma.